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Summary 
FceP,.Iy  (y) is a member of a group of related proteins  (the ~-family dimers)  that function  as 
signal-transducing  components  of both  Fc  receptors  and the  T  cell  antigen  receptor  (TC1K). 
Analysis of y  expression during fetal thymus ontogeny revealed that it is expressed in early thy- 
mocytes,  before  the  initiation  of clonotypic TC1K-e¢ and TC1K-]3  gene  rearrangement but is 
down-regulated in most adult thymocytes. To explore a possible role for y  in thymocyte de- 
velopment, we generated transgenic mice in which this protein was overexpressed at all stages 
of ontogeny.  Overexpression  of 3' inhibited  the maturation  of T  cells as well  as natural killer 
(NK)  cells.  The developmental  effects were transgene dose related and correlated with mark- 
edly delayed maturation of fetal CD4-CD8-  FcRII/III + thymocytes, cells thought to include 
the progenitors of both T  and NK cells. These results suggest that the ~ and y  chains serve dis- 
tinctive functions in thymocyte development and indicate  that Fc receptor(s)  may play an im- 
portant role in regulating the differentiation of early progenitor cells within the thymus. 
S 
ignals  transduced  by  the  TCR  regulate  the  stage-spe- 
cific  development and selection  (positive and negative) 
of thymocytes  (1,  2).  The  signal-transducing  potential  of 
the  TCR  complex  is  conferred  by multiple  subunits  (the 
CD3-y,  -8,  and-e,  and  the  {,  ~1,  or Fc~RIy chains)  that 
share a conserved structural  element,  the immunoreceptor 
tyrosine-based  activation  motif (ITAM) 1 (3).  A  consider- 
able  body  of evidence  supports  the  current  notion  that 
ITAMs, through their ability to facilitate activation of cyto- 
plasmic protein  tyrosine kinases,  mediate  all known TCR 
effector functions (4). 
The signals that regulate the earliest stages of thymocyte 
maturation are less understood. Precursor CD4-CD8-TCR- 
thymocytes populate  the  murine  thymus on  or about  day 
12  of gestation  (2).  These  early  thymocytes,  which  are 
thought to include  the precursors  of both T  cells and NK 
ceils  (5,  6)  progress through multiple  stages of differentia- 
tion  before  expressing  CD4,  CD8,  and  0t/]3TCR  (2,  7). 
l  Abbrevtanons used m this paper ADCC, antibody-dependent cellular cyto- 
toxlc~ry; DN,  double neganve; DP, double posmve; FCM, multicolor 
flow cytometry: fd, fetal day; "yTg, 2; transgemc, ITAM, mlmunoreceptor 
Wrosme-based activation mot~f~ poly(IC), polymosimc-polycytidyhc  acid. 
Although  the  molecular  events  that  regulate  their  transit 
through these various stages remain uncharacterized,  recent 
evidence  suggests  that  they  may receive  activating  signals 
through cell surface structures (8). The majori  W of early fe- 
tal thymocytes express low affinity receptors for lgG  (Fcy- 
iKII and/or FcylKIlI) (5).  FcylKIII is also expressed on ma- 
ture  NK  cells  where  it  functions  as  a  signal-transducing 
complex  to  mediate  antibody-dependent  cellular  cytotox- 
icity  (ADCC), and on a subset of mature T  cells  (9). These 
observations have led to speculation  that FcRIII may rep- 
resent  a  developmentally  important  signaling  structure  in 
early CD4-CD8-TCR-  thymocytes (5). 
In  mice,  the  FcyRIII e~  chain  forms  a  complex with  a 
dimer composed of FcelKIy chains (10,  11). Initially identi- 
fied as a subunit of the high affinity lgE receptor, FcelKIy is 
also  a  subunit  of the  high  affinity  IgG  receptor  (Fc'ylKI), 
and  in  a  subset  of T  cells,  functions  as  a  subunit  of the 
TClK complex (12-17). The structural and functional simi- 
larity  between  Fc~lKIy  and  ~ suggests  that  these  proteins 
are  members  of  a  family  of  signal-transducing  proteins 
whose genes were likely generated by duplication  (10,  18). 
Although  FcelKIy  is  reportedly  expressed  in  early  thy- 
mocytes,  its potential  role  in  thymocyte development  re- 
mains  controversial.  The  observation  that  T  cell  develop- 
ment is  unaffected  in  mice lacking FcelKI'y argues  that its 
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recent experiments indicate that Fc~ receptors on fetal thy- 
rnocytes may transduce  developmentally important signals 
(20).  In this study, we document that FceRIy is expressed 
early in  fetal thymic  ontogeny,  before  the  rearrangement 
and  expression  of  the  clonotypic  TCI~-(x  and  TCR-[3 
chains. To investigate the role ofFceRI-/in thymocyte de- 
velopment, we generated transgenic mice that express ele- 
vated levels of FceI~I',/ at all stages of fetal ontogeny. We 
found that overexpression of FceRI2~ inhibited the matura- 
tion of both T  cells and NK cells. The  developmental ef- 
fects were transgene dose related and were correlated with 
delayed maturation  of fetal  FcyRII/III  +  thymocytes  into 
FcyPdI/III-  thymocytes.  Collectively, these  results  show 
that  FceRI',/  can  regulate  the  differentiation  of an  early 
progenitor cell population within the thymus. 
Materials  and Methods 
DNA Constructs and Microinjection.  A 4.8-kb BclI genormc frag- 
ment containing the human FceRI',/("/) promoter and coding se- 
quences  (18) was cloned into the BamHI site of plasrnxd CD2- 
B-N2 (21) after removal of the SalI-BamHI fragment containing 
the  human  CD2  promoter  and  minigene.  A  9.8-kb  fragment 
composed of the ",/gene and the human CD2 3-pnme enhancer 
was then generated by digestion with NotI, separated from vector 
sequences by gel electrophoresis, punfied as described (22),  and 
used for pronuclear mjecnon. Transgenlc mice were identified by 
Southern blotting of tail DNA using the human CD2  enhancer 
sequences as a probe. 
Mice.  Transgemc  mice  were  generated by injection of zy- 
gotes obtained from matings of inbred FVB/N mice. Timed mat- 
ings were performed with either non Tg FVB/N males ×  non 
Tg C57BL/6J females or homozygous 2,551Tg  FVB/N males × 
non  Tg  C57BL/6J  females. The  first  day of mating was  desig- 
nated as day 0.5.  FVB/N  ×  C57BL/6J matings were performed 
because  staining  with  mAbs  2.4G2  (FcyRII/III)  and  PK136 
(NKI.1) were determined to be superior m the C57BL/6J back- 
ground;  however,  the  developmental effects  of the  "yTg were 
Identical regardless of the background. 
RNA Extraction and Analysis.  Purification of total thymocyte 
RNA and Northern  blot analysis  were  performed as described 
previously (22). cDNA probes for TCR-~x (Co~; 23) and TCP,,-[3 
(C~;  24)  were  provided by E.  Shevach  (National Institutes of 
Health  [NIH]).  ~ cDNA was provided by R.  Klausner (NIH). 
Human  (18)  and murine  (10)  FceRI  3,  cDNAs were  isolated as 
described. Human GAPDH cDNA was purchased from Clontech 
Laboratones, Inc. (Palo Alto, CA). 
Antibodies and Reagents.  mAbs used for flow cytometric anal- 
ysis included: FITC conjugated antl-Thy-l.1  (OX-7), anti-Thy 
1.2  (53-2.1), antl-CD4 (RM4.5), anti-TCR-[3 (H57-597),  anti- 
CD8c¢  (53-6.7),  anti-CD3e  (145-2Cll),  anti-CD2  (RNI2.5), 
anti-CD25  (7D4),  and anti-HSA (M1/69);  PE-conjugated anti- 
CD4  (RM4.5),  anti-CD8~x  (53-6.7),  ann-CD3e  (145-2Cll), 
anti-B220  (R,  A3-6B2),  and  anti-NKl.1  (PK136);  and biotiny- 
lated  antl-Fc3,RII/III  (2.4G2),  ann-CD8o~  (53-6.7),  antl-CD4 
(RM4.5),  anti-B220  (RA3-6B2),  ann-CD3e  (145-2Cll),  ann- 
CD5  (53-7.3). Unconjugated mAb 2.4G2 was additionally used 
to block nonspecific binding and for immunopreclpitanon. All of 
the aforementioned antibodies were purchased from PharMingen 
(San  Diego,  CA).  Streptavxdln-PE (PharMmgen)  and streptaw- 
din-Red 670 conjugate (GIBCO-BRL, Galthersburg, MD) were 
used as second step reagents. Bmtin  or FITC-conjugated anti- 
human  CD3  (mAb SK7; Becton Dickinson and Co.,  San Jose, 
CA) were used as control antibodies at a concentration of 10 Ixl/ 
10  6 cells. Anti-FceRI-/was generated m rabbit to a pepnde corre- 
sponding to amino acids 80-86  of human FceRI'v (25).  Rabbit 
anti-rat  sera  were  purchased  from  Jackson  lmmunoR,  esearch 
Laboratories (West Grove, PA). 
MulticolorFlow Cytometry (FCM).  Single  cell suspensions  (106 
cells/ml) of thymi or LN were washed twice in PBS containing 
0.5% BSA and 0.05% sodium azide before and after each incuba- 
tion with antibody. Cell suspensions were premcubated with un- 
conjugated mAb 2.4G2 to inhibit nonspeclfiC  staining unless cells 
were to be stained for Fc3~RII/III. Incubations with labeled mAb 
(10  txg/ml), streptavidin-PE or streptavidin-Red 670  were per- 
formed at 4°C for 30 rain. FCM was performed using a FACScan  ® 
flow cytometer (Becton Dickinson Immunocytometry Systems, 
Mountain View,  CA) and data were analyzed using FACScan  ® 
research software. Unless stated otherwise, fluorescence data were 
collected on 5 ×  104 cells, gating on viable cells as assessed by for- 
ward and side scatter profiles. In Fig. 6,  B and C, gates were set 
on  specific thymocyte subpopnlations at  the  time  of collecnon 
and data were collected on 4-5 ×  104 viable cells. Data were &s- 
played as logarithmic overlay histograms or dot plots. 
Protein Analysis.  Thymocytes were  lysed in  buffer  (0.15  M 
NaC1,  50 mM Tris-HC1, pH 7.4, 20 txg/ml leupeptin, 40 Ixg/rnl 
aprotmin) containing 1% NP-40 (adult thymocytes) or 1% digito- 
nm (fetal thymocytes), precleared with protein A-Sepharose plus 
normal rabbit serum,  then incubated with protein A-Sepharose 
plus 10 txl antisera. Immunopreclpitates were washed, solublllzed 
in loading buffer +  2ME, and resolved by 14% SDS-PAGE. Sep- 
arated proteins were then transferred to nitrocellulose and blotted 
with a  1:1,000 dilution of antl-'y. Detection of immunoreactive 
proteins was done by chermluminescence using the ECL system 
(Amersham Corp., Arlington Heights, IL). 
Cytotoxicity Assays.  Mice were injected with 100 Ixg ofpoly- 
inosmlc-polycytldyhc acid (poly[IC]) (Sigma Chemical Co.,  St. 
Louis,  MO).  Cytotoxicity assays were  performed with  spleno- 
cytes obtained 36 h after injectmn. Target cells were labeled with 
SlCr (Amersham Corp.)  at  100  IxCi/106 cells for  1 h  at 37°C, 
washed twine, and used in a standard 6 h S*Cr-release assay with 
2,500 target cells/well m 96-well V-bottom plates. Lysis was per- 
formed in RPMI  1640 medium containing 10% heat-inactivated 
FCS,  10  mM  Hepes,  and  500  U/ml  human  IL-2  (Hoffman- 
LaRoche,  Nutley, NJ).  NK activity was evaluated on the NK- 
sensitive target cell line, YAC-1. ADCC assays were performed 
essennally as described (5) with the exception that 3 mM rather 
than 30 mM 2,4,6-tnmtrobenzyl sulfonlc acid was used. 
Results 
Differential  Expression  of ~ and FcERI  T  during Fetal  Ontog- 
eny.  To  examine  the  normal pattern  of FceRIy  (~/) ex- 
pression during ontogeny, Northern blot analysis was per- 
formed on RNA  obtained from  thymi  on  sequential days 
of fetal development. "/transcripts were present on fetal day 
13.5, the earliest stage in which the thymus could clearly be 
identified in situ (Fig.  1). ~/ mRNA  levels were  highest at 
early  stages  of  development  (fetal  days  13.5-16.5),  de- 
creased progressively during late gestation, and were barely 
detectable  in  adult  thymocytes  (Fig.  1).  In  contrast,  low 
levels of ~ mRNA  were first detectable in the  thymus  on 
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Figure 1.  Expression of 3' and ~ transcripts in fetal thymus. 5 ~g of 
total thymocyte R.NA from sequential  days of gestation was resolved by 
formaldehyde/agarose electrophoresls, transferred to nylon membranes,  and 
hybn&zed with racholabeled probes denved fi'om  3', ~, TCR-ct, or TCR-[3 
cDNAs. Radiolabeled  human GAPDH cDNA was used as a control to as- 
sess equal loading. For TClk-ot, the size of the mature (1.7-kb) transcript 
is indicated. For TCR-{3, sizes of both the immature (1.0-kb) and mature 
(1.3-kb) transcripts are indicated Exposure tunes: ~ and TCR.-[3, 12 h, 
TCP,-0t, 24 h; ",/, 48 h. 
days  14.5-15.5  of fetal development and increased mark- 
edly  during gestation  to  high  levels in  adult  thymocytes 
(Fig.  1).  The pattern of ~ expression coincided temporally 
with  rearrangement and surface  expression  of the  clono- 
typic (TCR-ot and TCR-[3) chains (Fig. 1), an observation 
which is consistent with the central role of{ in ot/[3  T  cell 
receptor  (o~/[3 TCR)  surface  expression and signal trans- 
duction (26-29). On the other hand, "/predominates in fe- 
tal thymocytes during stages that precede expression of the 
clonotypic TCR-ot and TCR-[3 genes (Fig.  1).  The strik- 
ing difference in expression of y  and ~  during ontogeny 
suggested that these proteins might play distinctive roles in 
thymocyte development. To investigate this possibihty, we 
perturbed the normal pattern of~/expression by generating 
transgemc mice in which ~/ is  overexpressed in early thy- 
mocytes and continues to be expressed throughout devel- 
opment. 
Generation  of FcERI  y  Transgenic Mice.  The  Fc~P,  Iy  (y) 
transgene was  generated from a  4.8-kb BclI  genomic frag- 
ment contaimng the  human y  promotor  and  coding se- 
quences and a  5-kb genomic fragment containing the hu- 
man  CD2  3'-enhancer element  (18,  21;  Fig.  2  A).  Six 
independently derived  y  transgenic  (yTg)  founder  lines 
were  obtained by  microinjection of DNA  into  embryos 
derived from inbred strain FVB/N females. 
Transgene expression was detected by Northern blotting 
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Figure 2.  (A) Diagrammatic  representation  of the human (hu) FceRI3' 
transgene. A genomlc DNA fragment  containing the human 3" promoter 
and coding sequences was hgated to the human CD2 3-prime enhancer 
element (hatched  box, reference 21). Black  boxes represent exons (l-V); hnes 
represent lntrons. The NotI fragment  was punfied from vector sequences 
and used for rmcrolnlection.  (B) Quanntation ofy transgene  expression. 5 
~g of total P,.NA from adult thymus was electrophoresed through a form- 
aldehyde/agarose gel, transferred to  nylon membrane, and hybri&zed 
with a probe derived from human 31 cDNA. Transgene  expression  m the 
six founder hnes is compared with that of nontransgenic  (Non Tg) mace. 
The transgene  copy number for each founder hne (as assessed by South- 
em blotting) was: 3'371 (2), 3"514 (5); "/553 (8), 3"549 (12), 3'555 (25), 
3'551 (35). For P,  NA quantltatlon, membranes were stripped and re- 
probed with munne 3' cDNA (not shown). (C) Detecnon oftransgenlc 3' 
chain m thymocytes by lmmunoblot. Thymocytes (10  s) from adult Non 
Tg or 3' transgemc (founder  hne 3'514) mace were lysed, precleared, then 
incubated with protein A-Sepharose plus 10 ~1 anti-3'. Inmaunoprecipi- 
tates were washed, solublhzed in loading buffer and resolved by  14% 
SDS-PAGE. After transfer, mtrocellullose membranes were incubated 
with ant1-3'  followed by goat ann-rabbit horsera&sh peromdase and pro- 
reins were visualized  by chemdurmnescence. 
of total thymocyte RNA with radiolabeled human "y cDNA. 
RNA  expression correlated with transgene copy number, 
varying ~12-fold between the lowest (y371) and the highest 
(y551) expressing founder lines (Fig. 2  B). Both transgenic 
and endogenous (murine) transcripts were  expressed early 
in fetal ontogeny; however, unlike endogenous ~/mRNA, 
high level expression of the transgene continued through- 
out  thymocyte  development  (not  shown).  The  level  of 
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Figure 3.  Overexpresslon of y chain impairs thymocyte development. Thymocytes (left) and LN cells (right) from 4-wk-old nontransgemc (Non Tg) 
mice or from 4-wk-old ~/transgemc lines (~/514, y549, ~/551) expressing varymg levels of human 3' chain were stained and analyzed by two or one color 
FCM.  Two-color plots (columns  1 and  3)  show  staining of cells with  FITC  ann-CD4  vs.  biotin  antl-CD8  plus avlchn-PE. The  frequencies of 
CD4-CD8-, CD4-CD8 +, CD4+CD8 +, and CD4+CD8 - thymocytes, and CD4-CD8 + and CD4+CD8 - LN T cells are shown within their respective 
quadrants. Numbers on the left show total numbers of thymocytes for each line and are representanve of multiple samples. Single-color plots (columns 2 
and 4) were obtamed by staining wtth FITC anu-TCP,,-[3 mAb. Dotted hnes indicate staining with control antibody. For lymph node plots, numbers 
shown represent the mean fluorescence on TCR-I  3+ cells 
transgene  expression relative to  endogenous y  was  assessed 
by  sequentlai  hybridization  of northern  blots  with  human 
and mouse cDNA probes followed by densitometric  quan- 
titation.  Transgene  expression was estimated to be  50-fold 
(Tg line y371)  to 600-fold  (Tg line 3'551)  greater than en- 
dogenous m  adult thymocytes. In fetal day 15.5 thymocytes, 
the relative increase was less due to the higher level of en- 
dogenous y; 5-fold in Tg line y371  and 60-fold in Tg line 
y551  (not shown). 
Immunoblotting  with  antiserum  that  detects  both  hu- 
man and murine 3' chains demonstrated the presence of hu- 
man 3' chain in adult thymocytes from Tg mice  (Fig. 2  C-). 
After  prolonged  exposure,  a  far  less  abundant  protein  of 
identical mobility,  representing endogenous murine y, was 
also observed in  thymocytes from nontransgemc  mice  (not 
shown).  Given the high level of sequence conservation be- 
tween  human  and  murine  y  chains  (18)  it  was  expected 
that these proteins would be functionally equivalent.  Con- 
sistent  with  this  idea,  transgene-encoded  human  3'  chains 
assembled both as homodimers  and as heterodimeric  forms 
with  endogenous  murine  {  chain  (not shown).  Analysis  of 
proteins from both adult and fetal (day 17.5) thymocytes by 
two-dimensional SDS-PAGE  revealed that both {y and yy 
dimers  were  present  in  thymocytes  from  3'Tg  mice  and 
their  relative  abundance  predictably  increased  with  trans- 
gene copy number.  In contrast, ~3' and y3" dimers were vir- 
tually undetectable in adult nontransgenic mice (not shown). 
Dose-related Effects of the T  Transgene on  Thymocyte Devel- 
opment.  To  determine  the effect of 3"  overexpression on 
T  cell  development,  we  first  analyzed  the  phenotype  of 
adult  thymocytes from control  and 3'Tg mice.  Thymocyte 
numbers  were  reduced  in  yTg  mice  (Fig.  3;  Table  1). 
Moreover,  the effect of y  overexpressi'on on thymus cellu- 
lari W  was  transgene  dose  dependent  as  manifested  by  the 
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progressive  reduction in thymocyte number with  increas- 
ing  transgene  copy number  (Fig.  3;  Table  1).  Analysis of 
CD4  and CD8  expression on thymocytes from ~/Tg mice 
revealed  an  impairment  of thymocyte  maturation.  Low 
copy number transgenic  lines  exhibited  minimal  develop- 
mental defects whereas  high copy number transgenic lines 
exhibited  a  progressive  loss  of  mature  CD4+CD8 -  or 
CD4-CD8 + (single positive, SP) and CD4+CD8 + (double 
positive,  DP)  thymocytes  and  a  relative  increase  in  the 
number  of immature  CD4-CD8-  (double  negative,  DN) 
thymocytes (Fig. 3; Table 1). y  overexpression also resulted 
in a corresponding reduction in the number of peripheral 
T  cells  (Fig.  3).  Both  DP  and  SP  thymocytes  from yTg 
mice expressed ot/[3TC1L (Fig. 3).  In fact, though reduced 
in number, DP thymocytes from adult yTg mice expressed 
higher levels of ot/[3TClK than DP thymocytes from non- 
Tg mice (Fig. 3, data not shown).  Moreover, despite  their 
reduced  numbers,  peripheral  CD4 +  and  CD8 +  T  cells 
from yTg mice expressed ot/[3TCIL at levels comparable to 
controls (Fig. 3). 
Overexpression of~/did not result in complete develop- 
mental arrest, as all thymocyte subsets (DN, DP, and SP) as 
well as peripheral  T  cells  were present in adult ~Tg mice. 
The phenotype of adult yTg mice additionally suggested a 
block  in  early  thymocyte  development.  Numbers  of DP 
thymocytes were markedly reduced in high copy number 
("/551)  Tg mice (DN/DP ratio of 1.0 +  0.26; n =  5 com- 
pared to 0.03  +  0.01; n  =  5 for controls). In contrast,  the 
transition  of DP  thymocytes into  mature,  SP  thymocytes 
appeared less  affected as the SP/DP ratio in "y551 Tg mice 
(0.16  +  0.05; n  =  5), was identical to that of control mice 
(0.11  ---  0.03;  n  =  5).  Interestingly,  although both  CD4 + 
CD8-  SP  and  CD4-CD8 +  SP  thymocyte numbers  were 
reduced in ~Tg mice, CD4+CD8 -  thymocytes appeared to 
be more severely affected (Fig. 3; Table  1). A  skewed ratio 
of CD4+CD8  to  CD4-CD8 +  cells  was  also  seen  in  the 
lymph nodes of yTg mice indicating that the development 
ofCD4+CD8 -  T  cells may be selectively impaired (Fig. 3). 
y  Overexpression  Delays  Maturation  of  c~/IgTCR  +  T 
Cells.  To  determine  when  the  developmental  impair- 
ment was first evident in "/Tg mice we next analyzed pro- 
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Table 1.  Numbers of Thymocytes in FcERIT Transgenic  10  8_ 
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day of development 
Figure 4.  Thymocyte number vs. gestational age  Non Tg mice (ardes) 
"/551 Tg mice (squares). Datapolnts represent the mean +  1 SD obtained 
from multiple thymi. Numbers of thymocytes m Non Tg and ~/Tg mace 
were eqmvalent at fetal day 15.5. 
gressive stages of fetal thymocyte maturation.  Examination 
of fetal  thymocytes  from  high  copy  number  ("/551)  Tg 
mice revealed an early perturbation  of thymocyte matura- 
tion  (Figs.  4  and  5).  Total  numbers  of thymocytes were 
equivalent in control and "/551  Tg mice on day 15, but at 
all  subsequent  stages,  the  number  of thymocytes  in  ~/Tg 
mice was reduced relative  to nontransgenic  mice  (Fig.  4). 
By  fetal  day  17.5,  significant  numbers  of "transitional," 
CD4-CD8 l°  and  DP  thymocytes were  detectable  in nor- 
mal mice,  whereas  most thymocytes in the y551  Tg mice 
remained DN  (Fig.  5 A). DP and SP thymocytes began to 
accumulate in ",/551 Tg mice only after birth and the rela- 
tive  number  of DN  thymocytes  remained  high  even  in 
adult mice (Figs.  3 and 5). Thymocytes from y551Tg mice 
were immature relative to nontransgenic mice of the same 
gestational age by several other criteria.  For example,  most 
thymocytes from "/551 transgenic newborn mice resembled 
fetal thymocytes in that they were IL2-1Kot + and expressed 
low levels of surface CD2, CD5, and ot/[3TC1K (Fig. 5 B). 
Fetal Thymocyte Development Is Delayed at the CD4-CD8- 
FcTRII/III  + Stage in yTg Mice.  Since  our analysis  of fetal 
thymocytes 8om ~/Tg mice revealed a block at the DN--+DP 
transition  stage, we examined  the phenotype  of early DN 
thymocyte populations  in yTg mice.  Four distinct  subsets 
of precursor  "triple  negative"  (CD3-CD4-CD8-)  thy- 
mocytes  have  been  identified  on  the  basis  of CD44  and 
CD25 expression that represent progressive stages of develop- 
ment:  CD44+ CD25---+CD44+ CD25 +-->CD441°/-  CD25+ 
--+CD44-CD25-  (30).  FACS  ® analysis of DN  thymocyte 
subsets  from newborn ~/Tg mice revealed  a specific block 
in development at the CD44+/l°CD25 + stage (Fig. 5 C-'). The 
reduction in CD44-CD25  triple negative thymocytes was 
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Figure 5.  Delayed development of c¢/~ T  cells in y Tg mace. Tby- 
mocytes were obtained from fetuses (fd 15 5,fd17 5), newborn mice (dl), 
9-d-old rmce (d9), or 4-wk-old rmce (adult) generated by timed matmgs. 
For each time point other than d9 or adult, cells from mulnple thymi 
were combined and analyzed by two-color FCM. Data shown are repre- 
sentative of at least three  mdwldual experiments. (A) Staining of thy- 
mocytes with anu-CD4  and ann-CD8.  The frequencms of CD4-CD8-, 
CD4-CD8 +, CD4+CD8 +, and CD4+CD8 - thyrnocytes are indicated m 
their respective quadrants. (B) Immatunty of thymocytes from newborn 
~/Tg mice as assessed  by FCM. Total thymocytes from a pool of 15 Non 
Tg newborn mice or 7 "y551 Tg newborn mice were analyzed by FCM 
for expression of markers of thymocyte maturanon.  Single-color plots 
represent staining with  antl-TCR-[3,  antl-CD2,  ann-CD5  (Ly-1), or 
ann-IL2Rc((CD25).  Dotted hnes show staining wzth control annbody. 
(c) Comparison ofCD4-CD8- thymocyte subsets in newborn Non Tg and y551 Tg mice. Total thymocytes were stained with blotmylated antl-CD3, 
-CD4, -CD8, -B220 plus avldm-R670,  FITC-ann-CD44,  and PE-antiCD25. CD44 and CD25 surface expression was determined on CD3-,  4-,8-, 
B220- (max) negative thymocytes by gating. Mix-negative thymocytes were determined to be Thy 1.2 + by separate staining. 
consistent  with  the  low  numbers  of DP  thymocytes  ob- 
served m  ",/Tg mice as these cells are the immediate precur- 
sors of DP thymocytes (30).  Since ",/chain is known to as- 
sociate with FcyRIII we next examined expression of Fc',/ 
receptors on early thymocyte populations. Staining of fetal 
day 15.5  thymocytes with mAb 2.4G2  (31), which recog- 
nizes the  FcyRIIb  D Fc'yRIIb  2,  and  Fc'yRIII receptor iso- 
forms, revealed that the majority of thymocytes from con- 
trol and  ~/551  Tg mice  expressed FcyRII and/or  Fc'yRIII 
(Fig. 6 A, and reference 5).  The specificity of staining with 
mAb 2.4G2 was established by demonstrating that it could 
be blocked by unconjugated 2.4G2,  but not by unconju- 
gated isotype-matched mAb (not shown). In nontransgenic 
mice, the percentage of Fo/RII/III +  (2.4G2 +)  thymocytes 
decreased rapidly during gestation (Fig. 6 A, and reference 
5).  In  contrast,  the  percentage  of FcyRII/III  +  thymocytes 
remained high in "y551Tg mice  throughout  fetal develop- 
ment  (Fig.  6  A).  Because  total cellularity was  reduced  in 
"y551Tg  mice  (Fig.  4),  the  total  number  of FcyRII/III  + 
thymocytes was nevertheless equivalent to that of controls. 
Moreover, FcyRII/III  + thymocytes from fetal day 17.5 con- 
trol and "y551Tg mice appeared phenotypically sirmlar (i.e., 
Thy-I+CD4-CD8  CD3-HSA+;  data not shown).  These 
findings suggested that the high percentage of Fc'yRII/III  + 
thymocytes  in  "yTg  fetal  mice  reflected  their  failure  to 
progress further in development. 
Recent work has shown  that loss of FcI,  RII/III surface 
expression  precedes  the  differentiation  of  early  CD3- 
CD4-CD8-  thymocytes  to  the  DP  stage  (i.e.,  DN  Fcy- 
RII/III+-+DN  Fc~/RII/III--+DP FcyRII/III-;  [32]).  To 
determine  if thymocyte  development  was  blocked  at  the 
DN  Fo/RII/III+-+DN  FcyRII/III-  transition  stage  in 
y551Tg mice,  we  examined the surface expression of Fcy- 
RII/III on  fetal DN  thymocytes.  In  nontransgenic  mice, 
the percentage of DN  thymocytes that express Fc~/RII/III 
decreased from  61%  at fetal day  15.5  to  32%  at fetal day 
17.5,  and  those  cells that  remained positive expressed re- 
duced levels of Fc~/RII/III (Fig. 6  B).  Significant numbers 
of DP  thymocytes  were  first  detected  in  nontransgenic 
mice  on fetal day  17.5  (Fig. 6  B).  In contrast,  dunng  the 
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same  interval  (fetal  day  15.5-17.5),  DN  thymocytes  from 
yTg  mice  failed  to  differentiate  into  DP  thymocytes,  re- 
mained  predominantly  Fc'yRII/III +  and  continued  to  ex- 
press  high  levels  of  Fc',/RII/III  (Fig.  6  B).  Appreciable 
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Fc  7  RII/III 
Fc7  RII/III 
Figure 6.  (A) Expression of Fc~/RII 
and/or Fc~/RIII on fetal and adult thy- 
mocytes from Non Tg and ~/551 Tg 
mice. Total thymocytes were isolated 
from  timed  matmgs of Non  Tg  and 
"y551Tg mice at different stages of de- 
velopment  (see  Matenals  and  Meth- 
ods).  Fc~RII/III  expression  on  total 
thymocytes  (solid  lines)  was  analyzed 
by gating on  Thy  1.2 +  cells.  Dotted 
hnes show staining with control anti- 
body, although slrmlar plots were ob- 
tained when unlabeled 2 4G2 was added 
as  blocking  antibody  before  staimng 
with  conjugated  mAb  2.4G2.  Num- 
bers in the upper nght quadrants re&- 
care  the  percentage  of 2 4G2 +  cells. 
Total 2.4G2 + thymocyte numbers were: 
fd15.5, Non Tg, 8.6  X 10  4, 3'Tg, 7.5  X 
104; fd17.5, Non Tg, 1.4  X  105, "yTg, 
2.1  X  10s; NB, Non Tg, 2.4  X  105 , 
3'Tg,  4.8  X  105 .  (B)  Analysis  of 
Fc'yRII/llI expression on CD4  CD8 
thymocytes  from  nontransgemc  and 
3~551 Tg mice. Thymocytes were iso- 
lated from pooled fetal day 15.5 or fe- 
tal day 17.5 thyrm derived from timed 
matmgs.  Two-color plots show anti- 
CD4 vs. ann-CD8 stmmng.  For single- 
color  plots,  thymocytes were  stained 
with  FITC-antl-Thy  1 2,  then  anti- 
CD4-PE plus ann-CD8-PE, then bio- 
tinylated  anu-Fc~RIl/III  (2.4G2)  plus 
avldm-Red 670.  Profiles show 2.4G2 
staining on Thy-l.2 + CD4  CD8  thy- 
mocytes gated at the time of data col- 
lection. Dotted hne represents staining 
of gated  cells  with  control  antibody 
(slmdar  plots  were  obtained  when 
uncon3ugated mAb 2 4G2  was added 
as  blocking  antibody  before  staining 
with  blotinylated  mAb  2.4G2).  (C) 
Analysis  of Fc'yPdI/III expression on 
CD4-CD8-  and  CD4+CD8 +  thy- 
mocytes from newborn "/551Tg  mace. 
Two-color plots show CD4 vs.  CD8 
stalmng.  Single-color plots show 2.4G2 
staining on Thy-l.2 + CD4-CD8-  thy- 
mocytes  (left)  or  CD4+CD8 +  thy- 
mocytes (right).  Thy-l.2 + CD4-CD8- 
were  analyzed  as  described  in  B; 
CD4+CD8 + thymocytes were analyzed 
by stalmng v~th anfi-CD4-FITC, then 
anti-CD8-PE,  then blounylated 2.4G2 
plus avldin-Red 670  Gating on CD4 + 
CD8 +  thymocytes was  performed at 
the tmle of data collection. Dotted hne 
represents staining with  control  anti- 
body. 
numbers  ofDN  Fc~/RII/III-  thymocytes  were  first detect- 
able in newborn  y551Tg  mice, indicating that their forma- 
tion  was  delayed  relative  to  control  mice  (Fig.  6  C).  The 
appearance  of  DN  Fc~/RII/III-  thymocytes  in  newborn I- 
t- 
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Figure 7.  Colmmunoprecipitation of "/ chain with mAb 2.4G2. Fetal 
day 17.5 thymocytes from Non Tg (15 ×  106) or y Tg (8 ×  106) mace 
were lysed in buffer containing 1% digltonin, precleared with protein 
A-Sepharose plus normal rabblt serum, then  incubated with  protein 
A-Sepharose plus rabbit anti-rat anubody (lane 1), or rabbit anti-rat anti- 
body plus mAb 2.4G2 (lane 2). Immunopreclpltates  were washed, solubl- 
lized in reducing SDS loading buffer, and separated by SDS-PAGE (14%). 
Proteins were transferred to nitrocellulose and blotted with a 1:1,000 di- 
lution of  ann-"/sera  Immunoreactxve  proteins were detected by chemilu- 
minescence. Exposure Umes were 30 s for Non Tg samples and 3 s for 
"/Tg samples 
~/551Tg  mice  coincided with  the  appearance  of DP  thy- 
mocytes, which were also FcyRII/III- (Fig. 6  C).  Collec- 
tively, these observations indicate that y  overexpression de- 
lays the maturation ofDN  Fc~/R.II/III  + thymocytes. 
Expression of FcTRllI in Fetal 77zymocytes.  mAb  2.4G2  re- 
acts  with  three  distinct  FcyR isoforms  (tklIbl,  RIIb  2,  and 
Rill)  only one  of which  (Fc',/RIII) is  known to  associate 
with y  chain.  Consequently,  we were  interested  in deter- 
mining  whether  the  2.4G2  staining  on  fetal  thymocytes 
from 3'551Tg mice  reflected  expression  of Fc',/tLIII. Re- 
verse  transcription-PCR  analysis  demonstrated  that  tran- 
scripts for both FcyP,  IIb and FcyRIII (5;  data not shown) 
are  expressed  in both fetal and newborn  thymocytes from 
control and ~/551Tg mice. The presence of FcyRIII (ix +  y) 
complexes was then assessed  by immunopreclpitation  with 
m_Ab 2.4G2 followed by immunoblotting with anti-y chain 
sera.  As shown in  Fig.  7,  y  chain  could be  coprecipitated 
with  mAb 2.4G2  from both nonTg and y551Tg fetal day 
17.5 thymocyte lysates. However, the amount ofcoimmu- 
nopreclpitated  y  chain  was  significantly  greater  in  thy- 
mocyte lysates from fetal day 17.5 y551Tg mice. 
Impaired NK Cell Development in yTg Mice.  In  view  of 
recent data indicating that at least some NK cells  may orig- 
inate  from  early  Fc~/RIII  +  thymocyte progenitors  (5,  6), 
we  assessed  whether  NK  cell  development  was  compro- 
mised in ~/Tg mice.  Analysis of splenocytes  (Fig.  8 A)  and 
PBL  (not  shown)  demonstrated  that  the  number  of NK 
1.1 +  cells  was  reduced  in  y551Tg mice  relative  to  non- 
transgenic  controls.  In contrast, B  cell numbers were nor- 
mal  or elevated  in  these  mice  (Fig.  8  A).  As with  T  cells 
(indicated by staining with anti-Thy 1.2),  the reduction in 
NKI.1 + cells  was transgene dose dependent  (Fig. 8 A). To 
assess NK activity, nontransgenic  and ~/551  Tg mice were 
injected with poly(IC) and spleen cells  were assayed for cy- 
totoxicxty against the NK-sensitive target cell, YAC-1, and 
for ADCC. Consistent with the FACS  ® analysis, NK activ- 
ity and ADCC were negligible in y551 Tg mice (Fig. 8 B). 
Taken together,  these results demonstrate  that the number 
of NK cells  is markedly reduced in y551 Tg mice. 
Discussion 
The  present  study  was  directed  at  exploring  a  possible 
role for FceRb/in thymocyte development. Northern blot 
analysis of fetal and adult thymocytes demonstrate that ~/is 
expressed in the fetal thymus: expression is highest at early 
stages  (fetal  day  13.5-15.5),  and  decreases  progressively 
with  gestational  age.  This  pattern  contrasts  sharply  with 
that  of the  structurally  and  functionally  related  ~  chain, 
which is expressed later in development and functions pri- 
marily  as  a  signal-transducing  subumt  of the  ix/[3TCtL 
complex.  In view of these results,  we generated transgenic 
mice  that  overexpress  ",/, reasoning  that  a  perturbation  of 
thymocyte maturation,  if observed, might yield insight into 
its function in early thymocytes. Analysis of multiple trans- 
genic founder lines revealed that y  overexpression does in- 
deed impair  early thymocyte development.  The  transgene 
effects are dose related  and result in delayed maturation  of 
fetal DN thymocytes, with less severe effects on later stages 
of development. 
Analysis  of fetal  thymocytes  from  high  copy  number 
y551Tg mice revealed that ~/chain  overexpression specifi- 
cally blocked thymocyte development  at  the  DN  CD25 + 
Fc3'RII/RIII+-+DN  CD25-  FcytklI/P,  III-  transition 
stage.  As DN  Fc~/R.II/RIII  +  fetal thymocytes are  thought 
to include  common precursors  of T  lymphocytes and NK 
cells  (5),  it is  notable  that  NK cell  development was like- 
wise  impaired  in  ~/Tg mice.  Further  support  for the  idea 
that T  and NK cells  share a common precursor is provided 
by  the  observation  that  perturbation  of both  T  cell  and 
NK cell development was also observed in transgenic mice 
in  which  human  CD3e  was  overexpressed  in  early  thy- 
mocytes (33). 
One interpretation  of our observations is that the ~/trans- 
gene-induced effects  are mediated by Fc2*tLIII (CD16)  com- 
plexes on early thymocytes. Although the mAb used to assess 
FcyRII/III surface expression does not distinguish between 
these isoforms and therefore does not enable specific quan- 
titative  evaluation  of FcyRIII surface  expression,  Western 
blot analysis is consistent with  the idea that y  is  associated 
with  FcyRIIIix in  both  nontransgenic  and ~/Tg fetal  thy- 
mocytes. However, fetal day 17.5 thymocytes from y551Tg 
mice, which express high surface levels of Fc2/RII/III, con- 
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Figure  8.  (.4)  Reductmn  in 
NKI.1 + cells m ~vTg mice. Sple- 
nocytes from adult nontransgenic 
(NonT~a), y514Tg,  and  ~,551Tg 
rmce were stamed w~th ann-Thy 
1.2,  ann-B220,  or  ann-NKl.1, 
and  analyzed by  FCM.  Single- 
color  plots  are  shown. Dotted 
hne represents staining w~th con- 
trol antibody  Numbers m&cate 
percentage of total. Data are rep- 
resentanve of three independent 
experiments.  Total  NK 1.1 + 
cells: Non Tg, 3.0 ×  10~'; y514 
Tg, 3.7  ×  106; 3,551 Tg, 0.6  × 
106  (B) R.educuon m functional 
NK cells m  the  periphery of 
Tg  mice.  NK  acnvlty  was  as- 
sessed by cytotoxlcity of spleen 
cells from poly(IC)-treated Non 
Tg (open circles, n =  2) or y551 
Tg (closed ames, n =  3)  10-wk- 
old  C57BL/6  inbred  mace 
against the  NK-sensmve  target 
cell  hne,  YAC-1.  ADCC  was 
analyzed by  deterrmnmg  cyto- 
toxicity of splenocytes (obtained 
from the same rmce used to de- 
termine  NK  actlwty) against 
TNP-denvanzed  EL-4  cells 
coated with  ann-TNP annbody 
(EL-4-TNP)  or  non-TNP  de- 
nvanzed EL-4 cells (EL-4). R.e- 
suits  shown are  the  mean  4- 
SEM of triplicate samples. 
tained significantly greater amounts of FcyRIII (or +  ~) com- 
plexes than did age-matched controls, even when absolute 
numbers  of DN  thymocytes in each group  are taken into 
consideration.  These  findings  could  reflect  either  an  en- 
richment ofDN  FcyRIII  + thymocytes in y551Tg mice, or 
increased  surface  expression  of  Fc~RIII  on  thymocytes 
from y551Tg mice. Our own (Fig. 6) and previous data (5, 
32)  indicate that loss of surface Fc',/lq.II/III expression pre- 
cedes transition ofDN  thymocytes to the DP stage suggest- 
ing that down-regulation of Fc'yP,.II/III may be critical for 
this developmental transition. Thus, increased expression of 
Fc'yRIII complexes  or  Failure to  down-regulate  Fc'yR.III, 
might  inhibit the  further  differentiation of early DN  thy- 
mocytes.  Interestingly, the  major  effects  of "y overexpres- 
sion are observed in early thymocytes as later stages of mat- 
uration (that occur after down-regulation of Fc'yRII/RIII) 
are less affected. 
Seemingly inconsistent with  our data is the observation 
that  both  T  and  NK  cell  development  are  unaffected  in 
mice  rendered  "g  chain  deficient  by  gene  targeting  (19). 
Those results argue that if Fc~RIII constitutes a competent 
signal-transducing complex m  early thymocytes, such  sig- 
nals are not essential for thymocyte or NK cell maturation. 
Although  this  inconsistency  could be  explained by  func- 
tional redundancy,  our results favor a hypothesis in which 
y  chain provides a negative regulatory signal during devel- 
opment.  Increased or prolonged signaling by Fc',/RIII could 
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therefore  result in  maturational delay, whereas  absence of 
these  signals  might  either  appear  phenotypically silent  or 
result in accelerated differentiation. In support of this idea 
is  the  observation  that  DN  FcyRII/III  +  thymocytes  are 
developmentally delayed relative to DN  Fc~RII/III- thy- 
mocytes (32),  and that in fetal thymic organ culture, treat- 
ment with mAb 2.4G2,  which presumably blocks binding 
of Fo/R.II/III  to  their  natural  ligand(s),  accelerates  thy- 
mocyte differentiation (20).  Fc',/RIII could function  as an 
early signaling structure expressed on thymocytes before the 
rearrangement and expression of the clonotyplc  <x/I3TCP,. 
complex. Triggering of Fo/P,.III might occur either by di- 
rect interaction with its putative ligand or, as suggested pre- 
viously (5),  by its serving as a  coreceptor to  couple other 
surface structures (e.g., Thy-1  or CD2)  to intracellular sig- 
nal transduction pathways. 
It  is  also  possible  that  "y  chain  overexpression  inhibits 
thymocyte development through  indirect effects. Fc',/RIII 
overexpression could inhibit thymocyte development through 
sequestration of developmentally important molecules. For 
example, sequestration of p56  Ick, which has been shown to 
interact with "y chain as part of the Fc~/RIII complex (34), 
might  result  in  developmental  effects  such  as  those  de- 
scribed here.  In  addition,  although  "y  does  not  associate 
directly with  Fc'yP,.II, surface  expression  of this  receptor 
may also be  increased or its expression prolonged in "gTg 
mice. Fcyt<II has been shown to act as a negative regulator of hematopoetic cell activation (35); therefore its  failure to 
be  down-regulated  in  early  thymocytes  could  be  inhibi- 
tory.  Since  mAb  2.4G2  does  not  distinguish  between 
Fc3'RII and Fc3'R.III we were unable to discern the relative 
expression  of these  receptors  in  non-Tg and  3' Tg  mice. 
However,  both we  (data  not  shown)  and  others  (5)  have 
detected Fc3'P,  IIb expression during fetal thymocyte devel- 
opment  by  reverse  transcription-PCP,.  Notwithstanding, 
two lines  of evidence indicate  that  the  developmental  ef- 
fects observed in 3'Tg mice are specific to y  chain. First, we 
have previously shown that overexpression of both ~1 chain 
or a truncated form of ~ chain that,  like y, contains only a 
single ITAM does not inhibit  thymocyte maturation  (22). 
Second, reconstitution of~-deficient (~-/-) mice with y trans- 
genes revealed that the phenotype ofyTg mice is identical 
regardless of the presence of absence of endogenous ~ chain 
(data not shown).  These  results indicate  that  the  develop- 
mental effects of y  overexpression are not the  result of its 
association with ~ chain or due to competition with ~ chain 
for association with other molecules. 
The phenotype of 3'Tg and  ~Tg mice also provides In- 
sight  into  the  function  of these  molecules  in  developing 
thymocytes. Although T  cell development is adversely af- 
fected in both ~ and 3' transgenic mice, their phenotypes are 
strikingly different, y  chain overexpression delays, but does 
not arrest, thymocyte development at the DN Fc3'P,  II/III  + 
stage, whereas ~ chain overexpression results in a near com- 
plete arrest at a later stage of development  (22).  Fetal thy- 
mocytes from ~Tg mice but not 3'Tg mice are further dis- 
tinguished  by their  inappropriate  expression  of activation 
markers  and  premature  down-regulation  of  P,  agl  and 
II.ag2 (22).  These data suggest that y  and { may couple to 
different signaling pathways in early thymocytes. One pos- 
sibility is that y  and ~ associate preferentially with different 
cell  surface  structures,  e.g.,  ~  chain  along  with  the  CD3 
subunits  as part of the pre-TCR and oe/[3TCP, complexes, 
and  3'  chain  with  the  Fc3'RIII complex.  Indeed,  the  dis- 
tinctive  patterns  of 3'  and  ~  expression  during  gestation 
would be consistent with this idea. 
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